Chris Freeman
Chief Commercial Officer · 8 filings · Latest: Oct 1, 2026
Guardant Health, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GH | Chris Freeman | Chief Commercial Officer | Oct 1, 2026 | Option Exercise | $0.00 | 7,416 | — | 72,790 | |
GH | Chris Freeman | Chief Commercial Officer | Aug 10, 2026 | Sale | $169.58 | 63,605 | $10.8M | 65,374 | |
GH | Chris Freeman | Chief Commercial Officer | Aug 10, 2026 | Option Exercise | $74.09 | 63,605 | $4.7M | 128,979 | |
GH | Freeman Chris | — | Aug 10, 2026 | Proposed Sale | $169.58 | 63,605 | $10.8M | — | |
GH | Chris Freeman | Chief Commercial Officer | Jul 1, 2026 | Option Exercise | $0.00 | 7,414 | — | 68,515 | |
GH | Chris Freeman | Chief Commercial Officer | Jun 15, 2026 | Option Exercise | $0.00 | 1,402 | — | 61,695 | |
GH | Chris Freeman | Chief Commercial Officer | May 22, 2026 | Sale | $118.67 | 24,406 | $2.9M | 60,034 | |
GH | Chris Freeman | Chief Commercial Officer | May 22, 2026 | Option Exercise | $32.86 | 24,406 | $802.0K | 84,440 | |
GH | Freeman Chris | — | May 22, 2026 | Proposed Sale | $118.67 | 24,406 | $2.9M | — | |
GH | Chris Freeman | Chief Commercial Officer | Apr 1, 2026 | Option Exercise | $0.00 | 11,213 | — | 64,784 | |
GH | Chris Freeman | Chief Commercial Officer | Mar 15, 2026 | Option Exercise | $0.00 | 16,828 | — | 60,698 | |
GH | Freeman Chris | — | Dec 5, 2025 | Proposed Sale | $103.07 | 31,452 | $3.2M | — |